脚手架
骨桥蛋白
骨整合
骨钙素
松质骨
生物医学工程
骨愈合
化学
癌症研究
材料科学
体内
植入
碱性磷酸酶
病理
医学
解剖
外科
免疫学
生物
生物化学
生物技术
酶
作者
Xinyu Xu,Hao Wang,Xiaohan Mei,Dapeng Zeng,Zehao Yu,Shibo Liu,Ruiyan Li,Yanguo Qin
标识
DOI:10.1002/advs.202417346
摘要
Abstract Malignant bone tumor defects are difficult to treat because of the simultaneous need for tumor treatment and bone‐repair promotion. This study presents a bioactive composite scaffold (T‐rGO@Au) for personalized bone defect repair and bone tumor treatment. The T‐rGO@Au scaffold has a porous structure, and its mechanical properties are close to those of human cancellous bone. The T‐rGO@Au scaffold can induce upregulation of osteopontin (OPN), RUNX‐2, and osteocalcin (OCN) gene expression. In vivo experiments showed that the bone volume/total volume (BV/TV) ratio with the T‐rGO@Au scaffold was the highest. The new bone was tightly integrated with the implant, demonstrating effective osseointegration. The T‐rGO@Au scaffold locally generated high temperatures and reactive oxygen species under near‐infrared excitation, and AuNPs enhanced the photothermal performance of rGO through the “antenna effect.” Furthermore, in vitro experiments showed that the tumor cell nuclei were destroyed, late‐stage apoptotic cells increased, and cell morphology was severely damaged. Additionally, RNA‐seq revealed that tumor cell destruction was mediated through signaling pathways, such as the MAPK pathway. In vivo antitumor experiments also demonstrated that the T‐rGO@Au scaffold significantly inhibited the growth of tumor cells within 2 weeks. Thus, the T‐rGO@Au scaffold provides a new treatment strategy for the development of implantable scaffolds for bone tumor defects.
科研通智能强力驱动
Strongly Powered by AbleSci AI